Bisphenol-A dental sealants: the inappropriateness of continued reference to a single female patient. by Ashby, J
Corres pndence
Bisphenol-A Dental Sealants:
The Inappropriateness of
Continued Reference to a
Single Female Patient
Olea et al. (1) have described the collection,
chemical anlaysis, and bioassay using MCF-
7 cells in vitro of saliva taken from dental
patients treated with 50 mg of a dental
sealant based on bisphenol-A (BPA). Saliva
was collected overthe hourimmediatelyfol-
lowing treatment, and the main sampleana-
lyzed was shown to contain 231 pg BPA in
27 ml ofsaliva. Oleaet al. added thefollow-
ing statement to the Results section oftheir
paper: "A subject initially selected for treat-
ment had been treated with tooth sealant 2
years earlier; chromatograms demonstrated
the presence ofbisphenol-A (66.4 fig) and
bisphenol-A dimethacrylate (40.2 pg) in her
saliva before the second treatment." Olea et
al. did not condude that the BPA derived
from the dental treatment made 2 years ear-
lier, butthatwas implied.
Nagel et al. (2) have described how
they hand-fed 2 ppb or 20 ppb ofBPA in
corn oil, using a micropipettor, to preg-
nant mice between days 11 and 17 ofpreg-
nancy. The male pups ofthese animals had
increased prostate weights at 6 months of
age. When interpreting these data in terms
ofthe potential hazard ofhuman exposure
to BPA-based dental sealants, Nagel et al.
(2) referred again to the female patient
described by Olea et al. (1) as follows:
"They (Olea et al.) also measured bisphe-
nol A in the saliva of an individual who
had tooth sealant applied 2 years earlier
and found 66.4 pig in a 1-hr saliva collec-
tion before additional sealant treatment,
suggesting thatbisphenol Amaybe contin-
ually released after the initial dental work."
Here, there is a dear implication that the
BPA derived from the dental work carried
out 2 years previously.
Olea et al. (1) noted that most of the
unpolymerized sealant is leached from the
polymerized sealant within 24 hr. Given
that saliva is constantly swallowed and that
phenols such as BPAwould be expected to
be rapidly excreted, the relatively high lev-
els of BPA found in the saliva of the
patient treated 2 years previously must rep-
resent only a fraction ofthe levels present
immediately after the initial dental treat-
ment. However, even assuming constant
leaching of the BPA (66 pg/hr over 2
years), the original amount ofsealant used
would have been in excess ofa gram. If, as
is likely, the rate ofleaching was not con-
stant, the original treatment must have
involved the application ofmany grams of
the sealant. Such an unusual treatment
would require careful documentation
before it is used as a precendent for human
hazard assessment, and in the absence of
such documentation, it is suggested that
this anecdote should not be referred to
again in scientific papers.
The need for a balanced and scientific
evaluation ofthe hazard posed to humans
by dental treatments that use BPA-based
resins is enhanced in some countries (such
as the United Kingdom) where mercury-
based amalgums are still routinely
employed for restorative dental work. The
real need in such situations is for appropri-
ate relative risk assessments to be undertak-
en mindful ofthe effectiveness ofthe resin-
based treatments (3). Facedwith that need,
continued and undocumented reference to
the single female patient encounted by
Olea et al. (1) is unwarranted.
JohnAshby
Zeneca Central ToxicologyLaboratory
AlderleyPark, Cheshire, United Kingdom
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a2p, a2u, or a2u
I enjoy reading Environmental Health
Perspectives; thejournal is both highlyinfor-
mative and entertaining. Congratulations
for a job well done! However, in the
December 1996 issue ofVolume 104, I
came across an error that, in the interest of
scientific accuracy, needs to becorrected.
On pages 1264-1267 [EHP 104(12)],
there is a lively discussion between John
Ashby and James Huff on an issue that is
of interest to many of us: nephropathy,
white ravens (not rats!), and mechanisms.
Prominent in both title and text and,
above all, consistently, the text refers to a
protein called a2p (as in micro or macro)
globulin. I think the term a2ii globulin is
a misnomer. The protein in question is
called a2u globulin (u as in urine)-or at
least was called this way in the past. Two
reviews that are readily available in any
library (1,2) not only refer consistently to
tt2u globulin by its correct name but also
provide the necessary references to trace
the origin ofthis name. In reading some of
the earliest papers dating back to 1966, it
becomes indeed obvious that the u stands
for urinary.
It is easy to see how the mistake in ter-
minology can happen-most of us are too
lazy to consistently go through a few func-
tions in our word processing program, if it
can be avoided, to print a p (in myprogram
ittakes seven strokes) and thus usuallytype a
u instead-like in um, which reads microm-
eter, or umole for micromole. Also, we are
often too lazy to subscript letters. Therefore,
in typesetting an (XaUeasily becomes an a2p.
Butitdefinitelyis incorrect.
If it is of any consolation to you, you
are in good company. IARC Scientific
Publications No. 116, in chapters written
by Huff (3) and by Swenberg et al. (4),
consistently commits the same error in
both text and references. And when, on a
hunch, I checked one of the usually
superbly edited National Research Council
documents, I discovered the same error; in
"Science and Judgement in Risk
Assessment" (5), it consistently spells
alpha-2p-globulin, although in the refer-
ence list [see EPA (6)], the spelling is cor-
rect. This is embarrassing since I was a
memberofthe committee.
Environmental Health Perspectives is
thus not the only one having made the
error, but others did so aswell. It is an error
thatshould notbe furtherpropagated.
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